Table 4 Amino acid residues predicted as modifications sites.

From: Insight into molecular and mutational scrutiny of epilepsy associated gene Gabrg2 leading to novel computer-aided drug designing

Amino acid residues

Modification sites

High risk nsSNPs

T5

Phosphorylation, glycosylation

–

K7

Methylation, acetylation, SUMOylation ubiquitination sites

–

P8, P22

Hydroxylation

–

T9, T13

Phosphorylation, glycosylation

–

Y16

Phosphorylation

–

N18, N24, N27

Glycosylation

–

S19

Phosphorylation, glycosylation

–

S30

Phosphorylation, glycosylation

S30E

Q32

Proteolytic cleavage

Q32T

K34

Methylation, acetylation, SUMOylation ubiquitination sites

K34D

C38, C47

Pyrrolidone carboxylic acid

–

S41

Phosphorylation, glycosylation

–

K46

Methylation, acetylation, SUMOylation ubiquitination sites, hydroxylation

–